title: Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report.
abstract: This is a summary report of the conference on Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies. The conference was held from December 3 to 5, 1990 in the Washington, DC area and was sponsored by the American Association of Pharmaceutical Scientists, US Food and Drug Administration, Federation International Pharmaceutique, Health Protection Branch (Canada) and Association of Official Analytical Chemists. The purpose of the report is to represent our assessment of the major agreements and issues discussed at the conference. The report is also intended to provide guiding principles for validation of analytical methods employed in bioavailability, bioequivalence and pharmacokinetic studies in man and animals. The objectives of the conference were: 1. To reach a consensus on what should be required in analytical methods validation and the procedures to establish validation; 2. To determine processes of application of the validation procedures in the bioavailability, bioequivalence and pharmacokinetic studies; 3. To develop a report on analytical methods validation (which may be referred to in developing future formal guidelines). Acceptable standards for documenting and validating analytical methods with regard to processes, parameters or data treatments were discussed because of their importance in assessment of pharmacokinetic, bioavailability and bioequivalence studies. Other topics which were considered essential in the conduct of pharmacokinetic studies or in establishing bioequivalency criteria, including measurement of drug metabolites and stereoselective determinations, were also deliberated.
authors.affiliation: College of Pharmacy, University of Saskatchewan, Saskatoon, Canada.
authors.forename: V P
authors.initials: VP
authors.lastname: Shah
authors.forename: K K
authors.initials: KK
authors.lastname: Midha
authors.forename: S
authors.initials: S
authors.lastname: Dighe
authors.forename: I J
authors.initials: IJ
authors.lastname: McGilveray
authors.forename: J P
authors.initials: JP
authors.lastname: Skelly
authors.forename: A
authors.initials: A
authors.lastname: Yacobi
authors.forename: T
authors.initials: T
authors.lastname: Layloff
authors.forename: C T
authors.initials: CT
authors.lastname: Viswanathan
authors.forename: C E
authors.initials: CE
authors.lastname: Cook
authors.forename: R D
authors.initials: RD
authors.lastname: McDowall
mesh_terms: D001682:Biological Availability; D002623:Chemistry Techniques, Analytical / Q000592:standards; D007202:Indicators and Reagents; D010599:Pharmacokinetics; D011933:Reagent Kits, Diagnostic; D013237:Stereoisomerism; D009626:Terminology as Topic; D013810:Therapeutic Equivalency
chemical_list: D007202:Indicators and Reagents; D011933:Reagent Kits, Diagnostic